% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Schadendorf:303116,
      author       = {D. Schadendorf$^*$},
      title        = {{COLUMBUS} part 1-7-year results for encorafenib and
                      binimetinib in {BRAF} {V}600-mutant melanoma.},
      journal      = {Future oncology},
      volume       = {21},
      number       = {21},
      issn         = {1479-6694},
      address      = {London},
      publisher    = {Taylor $\&$ Francis},
      reportid     = {DKFZ-2025-01535},
      pages        = {2701-2703},
      year         = {2025},
      note         = {2025 Sep;21(21):2701-2703 / MULTIMEDIA ARTICLE},
      abstract     = {This summary presents 7-year results from COLUMBUS part 1,
                      which tested encorafenib (BRAFTOVI®) and binimetinib
                      (MEKTOVI®) (COMBO group), against encorafenib alone (ENCO
                      group), or vemurafenib (ZELBORAF®) alone (VEMU group) as a
                      treatment for a skin cancer called advanced or metastatic
                      BRAF V600-mutant melanoma.},
      keywords     = {7-year update (Other) / BRAF V600 (Other) / COLUMBUS
                      (Other) / Lead author commentary (Other) / binimetinib
                      (Other) / encorafenib (Other) / melanoma (Other) /
                      vemurafenib (Other)},
      cin          = {ED01},
      ddc          = {610},
      cid          = {I:(DE-He78)ED01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:40705373},
      doi          = {10.1080/14796694.2025.2536459},
      url          = {https://inrepo02.dkfz.de/record/303116},
}